EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism in vitro

Ping Fang, Jinhuan Ni, Taoye Shen, Qing Chen, Xinwu Ye, Jia Jin, Dapeng Dai, Guoxin Hu, Jianchang Qian, Jianping Cai, Lianguo Chen

PeerJ · 19.03.2026 · 14 · e20973

DOI: 10.7717/peerj.20973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 19.03.2026. Verfasst von Ping Fang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Acetamides, Cytochrome P-450 CYP2C9, Polymorphism, Genetic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genetic polymorphisms of CYP2C9 significantly influence the efficacy and safety of some drugs, which potentially lead to adverse effects and therapeutic failure. The aim of this study was to investigate the genetic polymorphism of 37 CYP2C9 alleles and evaluate their catalytic activities in agomelatine metabolism in vitro .

Methods

Insect microsomes expressing the 37 recombinant CYP2C9 variants were incubated in a 37 °C water bath with agomelatine. The main active metabolites of agomelatine were detected using a UPLC-MS/MS system. Then, the enzyme kinetic parameters of the 36 variants were calculated and compared with those of the wild-type CYP2C9*1.

Results

Relative to CYP2C9*1, four variants exhibited no significant difference in enzyme activity. Eleven variants exhibited significantly higher intrinsic clearance values, while 13 variants exhibited significantly reduced intrinsic clearance values. The remaining eight variants demonstrated complex metabolic patterns; these variants do not produce the two metabolites equally, and they inhibited the appearance of one metabolite but promoted the production of another metabolite. These results suggest that special attention should be given to subjects carrying poor metabolizers of CYP2C9 alleles when prescribing agomelatine in clinical practice. This study can provide valuable insights for personalized medicine and reduce adverse reactions to some extent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetamidesCytochrome P-450 CYP2C9Polymorphism, GeneticNaphthalenesAnimalsMicrosomesHumans

Stichwörter der Autor:innen

AgomelatineCYP2C9Genetic polymorphismRecombinant microsomesUPLC-MS/MS

Substanzen

agomelatineNaphthalenesAcetamidesCytochrome P-450 CYP2C9CYP2C9 protein, human

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Pharmacology, Wenzhou Medical University, Wenzhou, China.
  • Department of Psychiatry, Wenzhou Seventh People's Hospital, Wenzhou, China.
  • The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Beijing, China.
  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Fang, P., Ni, J., Shen, T., Chen, Q., Ye, X., Jin, J., Dai, D., Hu, G., Qian, J., Cai, J., & Chen, L. (2026). Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism in vitro. PeerJ, 14, e20973. https://doi.org/10.7717/peerj.20973

Vancouver

Fang P, Ni J, Shen T, Chen Q, Ye X, Jin J, et al. Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism in vitro. PeerJ. 2026;14:e20973. doi:10.7717/peerj.20973

BibTeX
@article{Fang2026,
  author = {Fang, Ping and Ni, Jinhuan and Shen, Taoye and Chen, Qing and Ye, Xinwu and Jin, Jia and Dai, Dapeng and Hu, Guoxin and Qian, Jianchang and Cai, Jianping and Chen, Lianguo},
  title = {Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism in vitro},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e20973},
  doi = {10.7717/peerj.20973}
}
Kostenlos starten →